Crescent Biopharma, Inc. $(CBIO)$ is currently at $18.77, down $3.60 or 16.09%
--Would be lowest close since April 13, 2026, when it closed at $17.99
--On pace for largest percent decrease since July 25, 2024, when it fell 24.2%
--Currently down three of the past four days
--Down 24.31% this week; worst weekly performance since the week ending Jan. 30, 2026, when it fell 25.08%
--Up 58.26% year-to-date
--Down 99.26% from its all-time closing high of $2535.00 on Feb. 15, 2018
--Down 28.25% from 52 weeks ago (May 2, 2025), when it closed at $26.16
--Down 31.67% from its 52-week closing high of $27.47 on May 5, 2025
--Up 109.96% from its 52-week closing low of $8.94 on Feb. 13, 2026
--Traded as low as $14.91; lowest intraday level since March 30, 2026, when it hit $14.25
--Down 33.35% at today's intraday low; largest intraday percent decrease since July 25, 2024, when it fell as much as 34.84%
All data as of 11:54:40 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 01, 2026 11:58 ET (15:58 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments